Personalizing Intervention to Reduce Clinical Inertia in the Treatment of Hypertension

NACompletedINTERVENTIONAL
Enrollment

511

Participants

Timeline

Start Date

October 26, 2021

Primary Completion Date

August 8, 2022

Study Completion Date

February 8, 2023

Conditions
Hypertension
Interventions
BEHAVIORAL

Audit and Feedback

A report of the provider's hypertension control rates compared to benchmark will be displayed using principles of social norming. We will present that provider's hypertension control rates compared to the 90th percentile of their peers.

BEHAVIORAL

Pharmacist E-Detailing

A pharmacist will review the chart in advance and provide a personalized recommendation for how to intensify the specific patient's antihypertensive regimen based on current guidelines. For example, they might recommend adding an additional medication based on the patient's comorbid conditions and could suggest a starting dose and timeframe for dose escalation.

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Brigham and Women's Hospital

OTHER

NCT04603560 - Personalizing Intervention to Reduce Clinical Inertia in the Treatment of Hypertension | Biotech Hunter | Biotech Hunter